Complementary and alternative medicine experience in radiation oncology patients: First results of a multi-center approach

Trace Elements and Electrolytes

Volumn 23, Issue 4, 2006, Pages 318-325

  Bruns, F ^a   Glatzel, M ^b   Schonekaes K ^c   Riesenbeck, D ^d   Mucke R ^e   Buntzel J ^f   Micke, P ^g   Schafer U ^d   Kisters, K ^h   Micke, O ^d,i  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Central Hospital   (Germany)

^c KLINIKUM MINDEN   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^e Frauenklinik   (Germany)

^f Sudharz Hospital   (Germany)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h ST ANNA HOSPITAL   (Germany)

ⁱ FRANZISKUS HOSPITAL   (Germany)

Author keywords

Cancer; Complementary and alternative medicine (CAM); Radiotherapy; Trace elements

Indexed keywords

MISTLETOE EXTRACT; PLANT EXTRACT; SELENIUM; TRACE ELEMENT; UNCLASSIFIED DRUG; VITAMIN;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER STAGING; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SELF EVALUATION; SEX DIFFERENCE;

EID: 33750413682     PISSN: 09462104     EISSN: None     Source Type: Journal    
DOI: 10.5414/tep23318     Document Type: Article

References (42)

1. Asher BF, Seidman M, Snyderman C. Complementary and alternative medicine in otolaryngology. Laryngoscope. 2001; 111: 1383-1389.
2. Astin JA. Why patients use alternative medicine: results of a national study. JAMA. 1998; 279: 1548-1553.
3. Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, McWilliam C, Gavin A, Baron RA, Aaron D, Haines-Kamku T. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol. 2000; 18: 2515-2521.
4. Bruns F, Büntzel J, Mücke R, Micke O, Kisters K. 2004 Selected Abstracts of the Fifth Münster Workshop on Trace Elements and Electrolytes, AKTE 2/2003, Hannover, Germany, November 15, 2003. Trace Elem Electrolytes. 2004; 21: 281-286.
5. Bruns F, Mücke R, Büntzel J, Kisters K, Micke O. Trace elements supplementation in radiation oncology - an empirical study assessing the quality of health information for consumers on the World Wide Web in Germany. Trace Elem Electrolytes. 2005; 22: 311-315.
6. Büntzel J, Glatzel M, Schönekaes KG, Kisters K, Bruns F, Mücke R, Micke O. Complementary and alternative medicine in head and neck cancer - interviews with 300 patients (abstract). Trace Elem Electrolytes. 2005; 22: 70-71.
7. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med. 1999; 340: 1733-1739.
8. Burstein HJ. Discussing complementary therapies with cancer patients: what should we be talking about? J Clin Oncol. 2000; 18: 2501-2504.
9. Cassileth BR, Deng G. Complementary and alternative therapies for cancer. Oncologist. 2004; 9: 80-89.
10. D'Amico AV, Toupless G, Lopes L, Valentine KJ, Cormack RA, Tempany CM, Kumar S, Marks PJ. Self-administration of untested medical therapy for treatment of prostate cancer can lead to clinically significant adverse events. IJROBP. 2004; 54: 1311-1313.
11. Druss BG, Rosenheck RA. Association between use of unconventional therapies and conventional medical services. JAMA. 1999; 282: 651-656.
12. Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer. 1998; 83: 777-782.
13. Ernst E. Harmless herbs? A review of the recent literature. Am J Med. 1998; 104: 170-178.
14. Ernst E. The role of complementary and alternative medicine in cancer. Lancet Oncol. 2000; 1: 176-180.
15. Ernst E. Intangible risks of complementary and alternative medicine. J Clin Oncol. 2001; 19: 2365-2366.
16. Frenkel M, Arye EB. The growing need to teach about complementary and alternative medicine: questions and challenges. Acad Med. 2001; 76: 251-254.
17. Grunberg SM. Stage shift and complementary/alternative medicine. J Clin Oncol. 2000; 18: 3455-3456.
18. Kessler RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, Wilkey SA, Kaptchuk TJ, Eisenberg DM. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med. 2001; 735: 262-268.
19. Lamson DW, Brignatt MS. Antioxidants in cancer therapy, their actions and interactions with oncologic therapies. Altern Med Rev. 1999; 4: 304-329.
20. Markman M. Safety issues in using complementary and alternative medicine. J Clin Oncol. 2002; 20: 39S-41S.
21. Masironi R, Chazot G, Bost M. The Trace Element Institute for UNESCO (abstract). Trace Elem Electrolytes. 2005; 22: 77.
22. Micke O, Mücke R, Schönekaes K, Büntzel J. Complementary and alternative medicine in radiotherapy patients - more harm than expected? In regard to D'Amico et al: Self-administration of untested medical therapy for treatment of prostate cancer can lead to clinically significant adverse events. IJROBP. 2002; 54: 1311-1313.
23. IJROBP 2002; 57: 1197-1198.
24. Micke O, Büntzel J, Bruns F, Glatzel M, Schönekaes KG, Kisters K, Mücke R. Selenium in oncology - past, presence and future (abstract). Trace Elem Electrolytes. 2005; 22: 66.
25. Morris KT, Johnson N, Homer L, Walts D. A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg. 2000; 179: 407-411.
26. Mücke R, Glatzel M, Riesenbeck D, Bernd-Skorka R, Seifert G, Büntzel J, Schönekaes KG, Bruns F, Kisters K, Micke O. Sodium selenite in gynecologic radiation oncology - first results of aphase III study. Trace Elem Electrolytes. 2004; 21: 78-82.
27. Münstedt K. Ratgeber unkonventionelle Krebstherapien (2. Auflage). Landsberg: ecomed; 2005.
28. NCCAM. What is complementary and alternative medicine (CAM)? National Institutes of Health: National Center for Complementary and Alternative Medicine (NCCAM); 2002. URL: http://nccam.nih.gov/health/whatiscam/.
29. Niggemann B, Gruber C. Side-effects of complementary and alternative medicine. Allergy. 2003; 58: 707-716.
30. Paltiel O, Avitzour M, Peretz T, Cherny N, Kaduri L, Pfeffer RM, Wagner N, Soskolne V. Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol. 2001; 19: 2439-2448.
31. Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ, Marshall LM. Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med. 2002; 8: 477-485.
32. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000; 18: 2505-2514.
33. Risberg T, Lund E, Wist E. Use of non-proven therapies. Differences in attitudes between Norwegian patients with non-malignant disease and patients suffering from cancer. Acta Oncol. 1995; 34: 893-898.
34. Risberg T, Lund E, Wist E, Kaasa S, Wilsgaard T. Cancer patients use of nonproven therapy: a 5-year follow-up study. J Clin Oncol. 1998; 16: 6-12.
35. Sagar SM. Complementary medicine: Integration in radiation oncology practice. In: ASTRO (ed). Refresher Course within the 44th Annual Meeting of the American Society of Therapeutic Radiology and Oncology (ASTRO). New Orleans, LA: ASTRO 2002.
36. Schmidt K, Ernst E. Assessing websites on complementary and alternative medicine for cancer. Ann Oncol. 2004; 15: 733-742.
37. Schönekaes K, Schüller P, Micke O, Mücke R, Büntzel J, Bruns F, Kisters K, Panke J, Wagner W. An analysis of complementary/ alternative medicine (CAM) use by radiotherapy patients. Trace Elem Electrolytes. 2001; 18: 181-185.
38. Söllner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P. Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer. 2000; 89: 873-880.
39. Tindle HA, Davis RB, Phillips RS, Eisenberg DM. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med. 2005; 11: 42-49.
40. Verhoef MJ, Hagen N, Pelletier G, Forsyth P. Alternative therapy use in neurologic diseases: use in brain tumor patients. Neurology. 1999; 52: 617-622.
41. Verhoef MJ, Casebeer AL, Hilsden RJ. Assessing efficacy of complementary medicine: adding qualitative research methods to the "Gold Standard". J Altern Complement Med. 2002; 8: 275-281.
42. Werneke U, Earl J, Seydel C, Horn O, Crichton P, Fannon D. Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer. 2004; 90: 408-413.